CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Director acquired 20,537 shares (grant or award)
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 4 Other acquisition Director acquired 30,000 shares (other)
- 4 Other acquisition President and CEO acquired 4,500 shares (other)
- 4 Other acquisition Director acquired 1,800 shares (other)
- 4 Other acquisition Director acquired 3,600 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 3,000 shares (other)
- 4 Other acquisition Director acquired 3,600 shares (other)
- 4 Other acquisition Director acquired 25,500 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 29 · 576 filings